L. Rydlander

745 total citations
17 papers, 644 citations indexed

About

L. Rydlander is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, L. Rydlander has authored 17 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Genetics. Recurrent topics in L. Rydlander's work include Protist diversity and phylogeny (9 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). L. Rydlander is often cited by papers focused on Protist diversity and phylogeny (9 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). L. Rydlander collaborates with scholars based in Sweden, Germany and Austria. L. Rydlander's co-authors include J. -E. Edstr�m, Ulrik Ringborg, A. Pigon, Christof Francke, E. Egyházi, Jan‐Erik Edström, R. Einarsson, Maria C. Shoshan, Stig Linder and Maria Hägg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Journal of Molecular Biology.

In The Last Decade

L. Rydlander

17 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Rydlander Sweden	12	465	97	90	85	65	17	644
Marilyn L. Cayer United States	15	257 0.6×	154 1.6×	53 0.6×	64 0.8×	75 1.2×	37	837
Merrill B. Hille United States	17	659 1.4×	205 2.1×	62 0.7×	125 1.5×	51 0.8×	34	921
Gordon P. Moore United States	16	572 1.2×	42 0.4×	52 0.6×	175 2.1×	29 0.4×	24	830
Giovanni Spinelli Italy	20	775 1.7×	69 0.7×	57 0.6×	166 2.0×	26 0.4×	58	1.0k
K. Yamana Japan	21	1.1k 2.4×	132 1.4×	78 0.9×	308 3.6×	64 1.0×	68	1.4k
Mark C. Alliegro United States	18	481 1.0×	146 1.5×	51 0.6×	97 1.1×	40 0.6×	42	775
Monika Abedin United States	6	483 1.0×	157 1.6×	85 0.9×	233 2.7×	39 0.6×	14	653
Gregory J. Dolecki United States	16	433 0.9×	32 0.3×	30 0.3×	125 1.5×	40 0.6×	23	778
Melvin Spiegel United States	18	321 0.7×	102 1.1×	43 0.5×	74 0.9×	48 0.7×	43	843
Maki Yoshio Japan	9	514 1.1×	108 1.1×	37 0.4×	103 1.2×	76 1.2×	19	720

Countries citing papers authored by L. Rydlander

Since Specialization

Citations

This map shows the geographic impact of L. Rydlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Rydlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Rydlander more than expected).

Fields of papers citing papers by L. Rydlander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Rydlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Rydlander. The network helps show where L. Rydlander may publish in the future.

Co-authorship network of co-authors of L. Rydlander

This figure shows the co-authorship network connecting the top 25 collaborators of L. Rydlander. A scholar is included among the top collaborators of L. Rydlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Rydlander. L. Rydlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hägg, Maria, Takayuki Ueno, L. Rydlander, et al.. (2002). A Novel High-Through-Put Assay for Screening of Pro-Apoptotic Drugs. Investigational New Drugs. 20(3). 253–259. 107 indexed citations

Einarsson, R. & L. Rydlander. (1997). Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin.. PubMed. 17(4B). 3121–4. 15 indexed citations

Rydlander, L., Tomas Bergman, Georg Steiner, et al.. (1996). Molecular Characterization of a Tissue‐Polypeptide‐Specific‐Antigen Epitope and its Relationship to Human Cytokeratin 18. European Journal of Biochemistry. 241(2). 309–314. 72 indexed citations

Sandberg, Göran, et al.. (1987). Purification, Identification and Elimination of a Natural Human Serum Antibody with Cytotoxic Effect on Guinea Pig Thymocytes. International Archives of Allergy and Immunology. 83(1). 57–63. 1 indexed citations

Rydlander, L., Helena Anundi, & Olof Vesterberg. (1986). Modified procedures for high resolution two dimensional electrophoresis and silver staining of proteins. 611–612. 2 indexed citations

Galler, Ricardo, L. Rydlander, N Riedel, H. Kluding, & Jan‐Erik Edström. (1984). Balbiani ring induction in phosphate metabolism. Proceedings of the National Academy of Sciences. 81(5). 1448–1452. 39 indexed citations

Rydlander, L.. (1984). Isolation and characterization of the two giant secretory proteins in salivary gland of Chironomus tentans. Biochemical Journal. 220(2). 423–431. 11 indexed citations

Holst, Mikael, et al.. (1983). Fractionation and characterization of rapidly phosphorylated nuclear proteins in salivary gland cells of Chironomus tentans. Chromosoma. 88(1). 24–30. 10 indexed citations

Edström, J.-E., L. Rydlander, & J Thyberg. (1983). Spread of Balbiani ring derived messenger RNA in Chironomus salivary gland cell cytoplasm.. PubMed. 29(2). 281–7. 1 indexed citations

10.

Egyházi, E., et al.. (1982). 5,6‐Dichlororibofuranosylbenzimidazole Inhibits the Rate of Transcription Initiation in Intact Chironomus Cells. European Journal of Biochemistry. 122(3). 445–451. 33 indexed citations

11.

Edstr�m, J. -E., L. Rydlander, & Christof Francke. (1980). Concomitant induction of a Balbiani ring and a giant secretory protein in Chironomus salivary glands. Chromosoma. 81(1). 115–124. 56 indexed citations

12.

Rydlander, L. & J. -E. Edstr�m. (1980). Large sized nascent protein as dominating component during protein synthesis in Chironomus salivary glands. Chromosoma. 81(1). 85–99. 65 indexed citations

13.

Rydlander, L., A. Pigon, & J. -E. Edstr�m. (1980). Sequences translated by Balbiani ring 75S RNA in vitro are present in giant secretory protein from Chironomus tentans. Chromosoma. 81(1). 101–113. 66 indexed citations

14.

Edstr�m, J. -E., et al.. (1978). Balbiani ring RNA content and half-life in nucleus and cytoplasm of Chironomus tentans salivary gland cells. Chromosoma. 66(1). 33–44. 20 indexed citations

15.

Edström, J.-E., et al.. (1978). Fate of Balbiani-ring RNA In Vivo. Cold Spring Harbor Symposia on Quantitative Biology. 42(0). 877–884. 14 indexed citations

16.

Ringborg, Ulrik & L. Rydlander. (1971). NUCLEOLAR-DERIVED RIBONUCLEIC ACID IN CHROMOSOMES, NUCLEAR SAP, AND CYTOPLASM OF CHIRONOMUS TENTANS SALIVARY GLAND CELLS. The Journal of Cell Biology. 51(2). 355–368. 95 indexed citations

17.

Ringborg, Ulrik, Bertil Daneholt, Jan‐Erik Edström, E. Egyházi, & L. Rydlander. (1970). Evidence for transport of preribosomal RNA from the nucleolus to the chromosomes in Chironomus tentans salivary gland cells. Journal of Molecular Biology. 51(3). 679–686. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact